A research study looking into how cagrilintide influences food intake and appetite in people with overweight or obesity
NN9833-8421
Phase 1 other active
Quick answer
A research study looking into how cagrilintide influences food intake and appetite in people with overweight or obesity for Obesity is a Phase 1 program (other) at Novo Nordisk A/S with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Novo Nordisk A/S
- Indication
- Obesity
- Phase
- Phase 1
- Modality
- other
- Status
- active